MCL management algorithm. Allo-SCT, allogeneic stem cell transplantation; BR, bendamustine-rituximab; R + HD-AraC, rituximab plus high-dose cytarabine; R-chemo, rituximab plus chemotherapy; R-Len, rituximab-lenalidomide.